A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2015
At a glance
- Drugs Vilanterol (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jun 2013 Planned end date changed from 1 Feb 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.